|
Volumn 9, Issue 14, 2011, Pages 5249-5259
|
Prodrug design for the potent cardiovascular agent Nω- hydroxy-l-arginine (NOHA): Synthetic approaches and physicochemical characterization
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOACTIVATION;
CARDIO-VASCULAR DISEASE;
ENDOTHELIAL DYSFUNCTION;
NOVEL CONCEPT;
OXIDATIVE STABILITY;
OXIDE PRECURSORS;
PHYSICO-CHEMICAL CHARACTERIZATION;
POTENT INHIBITOR;
PRODRUGS;
SYNTHASES;
SYNTHETIC APPROACH;
SYNTHETIC ROUTES;
THERAPEUTIC TOOLS;
ARGININE;
NITRIC OXIDE;
POSITIVE IONS;
ARGININE;
CARDIOVASCULAR AGENT;
DRUG DERIVATIVE;
N(OMEGA) HYDROXYNORARGININE;
N(OMEGA)-HYDROXYNORARGININE;
PRODRUG;
ARTICLE;
CHEMICAL STRUCTURE;
CHEMISTRY;
DRUG DESIGN;
PH;
PHYSICAL CHEMISTRY;
STEREOISOMERISM;
SYNTHESIS;
ARGININE;
CARDIOVASCULAR AGENTS;
CHEMISTRY, PHYSICAL;
DRUG DESIGN;
HYDROGEN-ION CONCENTRATION;
MOLECULAR STRUCTURE;
PRODRUGS;
STEREOISOMERISM;
|
EID: 79959787734
PISSN: 14770520
EISSN: None
Source Type: Journal
DOI: 10.1039/c0ob01117g Document Type: Article |
Times cited : (16)
|
References (48)
|